RVMD affiliate files Rule 144 notice for 2,958 shares

Revolution Medicines, Inc. sale notice by affiliate Jeff Cislini for Common Stock under Rule 144.

Rhea-AI Filing Summary

Revolution Medicines, Inc. sale notice by affiliate Jeff Cislini for Common Stock under Rule 144. The filing lists two reported dispositions: 1,795 shares sold on 03/17/2026 for $178,567.32 and 1,163 shares sold on 03/19/2026 for $113,322.72. The form also lists several restricted stock unit grants with grant dates and share counts as background.

Insights

Corporate Governance Analyst

Routine Rule 144 sale notices by an affiliate; transactional detail is limited.

The excerpt records two specific dispositions by Jeff Cislini: 1,795 shares on 03/17/2026 and 1,163 shares on 03/19/2026

These entries are transaction-level disclosures required for affiliate sales; the filing does not state who receives proceeds beyond the listed dollar amounts or whether sales followed a pre-arranged plan.

Key Figures

Disposition 1: 1,795 shares Proceeds 1: $178,567.32 Disposition 2: 1,163 shares +5 more

8 metrics

Disposition 1 1,795 shares sold on 03/17/2026

Proceeds 1 $178,567.32 proceeds from 03/17/2026 disposition

Disposition 2 1,163 shares sold on 03/19/2026

Proceeds 2 $113,322.72 proceeds from 03/19/2026 disposition

RSU grant 09/01/2022 193 shares restricted stock unit grant dated 09/01/2022

RSU grant 03/01/2023 498 shares restricted stock unit grant dated 03/01/2023

RSU grant 03/01/2024 471 shares restricted stock unit grant dated 03/01/2024

RSU grant 03/01/2025 494 shares restricted stock unit grant dated 03/01/2025

Key Terms

Form 144, Restricted stock unit grant, Issuer, Proceeds

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted stock unit grant financial

"Common Stock | 09/01/2022 | Restricted stock unit grant"

Issuer regulatory

"Restricted stock unit grant | Issuer"

Proceeds financial

"1795 | 178567.32"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RVMD Form 144 disclose about Jeff Cislini's sales?

It discloses two specific sales totaling 2,958 shares. The filing lists 1,795 shares on 03/17/2026 and 1,163 shares on 03/19/2026, with proceeds of $178,567.32 and $113,322.72 respectively.

Do the listed restricted stock unit grants affect the Form 144 sales?

The form shows prior RSU grants dated 09/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025 with counts of 193, 498, 471, and 494. The filing presents these as background; it does not state their relation to the sales.

Does the filing state whether proceeds go to the issuer or seller?

The filing shows dollar proceeds for each disposition but does not state who receives the proceeds. The entries list proceeds amounts of $178,567.32 and $113,322.72 without attributing recipient.

What regulatory purpose does Form 144 serve for RVMD insiders?

Form 144 notifies the SEC of an affiliate's intent to sell restricted or control securities. It supplies transaction dates, share counts, and proceeds, fulfilling disclosure requirements for affiliate dispositions under the rule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 06:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001969082
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 SAGINAW DR REDWOOD CITY CALIFORNIA 94063
Phone	4157663638
Name of Person for Whose Account the Securities are To Be Sold	Cislini Jeff
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	1656	254808.72	212596462	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/01/2022	Restricted stock unit grant	Issuer			193	09/01/2022	Services rendered
Common Stock	03/01/2023	Restricted stock unit grant	Issuer			498	03/01/2023	Services rendered
Common Stock	03/01/2024	Restricted stock unit grant	Issuer			471	03/01/2024	Services rendered
Common Stock	03/01/2025	Restricted stock unit grant	Issuer			494	03/01/2025	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeff Cislini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	03/17/2026	1795	178567.32
Jeff Cislini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	03/19/2026	1163	113322.72

144: Remarks and Signature

Remarks
Date of Notice	06/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/31/2023
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jack Anders, as Attorney-in-fact for Jeff Cislini
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)